---
input_text: Erythrocytapheresis in a Patient of Sickle Cell Disease Presenting in
  Crisis.As per American Society of Apheresis (ASFA) guidelines, the indication for
  Erythrocytapheresis for sickle cell patients is category III for preoperative management
  and vaso-occlusive crisis. Erythrocytapheresis, with the help of automated cell
  separators, has the benefit of reducing the Sickle hemoglobin (HbS) levels to <30.0%
  with a reduced risk of increasing blood viscosity and single procedure achieving
  target hemoglobin levels. A 17-year-oldfemale patient who was a known case of sickle
  cell disease presented to our institution with a vascular necrosis of the right
  femoral head. Due to the pain and limitations of her day-to-day activities, she
  was advised for total hip arthroplasty. This patient underwent a successful Erythrocytapheresis
  using an automated cell separator and was operated on. In a sickle cell patient
  planned for surgical intervention, the procedure of Erythrocytapheresis can help
  in decreasing the chances of the patient developing any vaso-occlusive crisis during
  surgery and in the immediate post-operative period. This technique can help in improving
  the chances of a successful surgical procedure for such patients.
raw_completion_output: |-
  primary_disease: Sickle Cell Disease
  medical_actions: Erythrocytapheresis; Total hip arthroplasty
  symptoms: Vascular necrosis of the right femoral head; Pain; Limitations of day-to-day activities; Vaso-occlusive crisis
  chemicals: 
  action_annotation_relationships: Erythrocytapheresis TREATS Vascular necrosis of the right femoral head IN Sickle Cell Disease; Total hip arthroplasty TREATS Pain IN Sickle Cell Disease; Total hip arthroplasty TREATS Limitations of day-to-day activities IN Sickle Cell Disease; Erythrocytapheresis PREVENTS Vaso-occlusive crisis IN Sickle Cell Disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Erythrocytapheresis PREVENTS Vaso-occlusive crisis IN Sickle Cell Disease

  ===

extracted_object:
  primary_disease: MONDO:0011382
  medical_actions:
    - Erythrocytapheresis
    - Total hip arthroplasty
  symptoms:
    - Vascular necrosis of the right femoral head
    - HP:0012531
    - Limitations of day-to-day activities
    - Vaso-occlusive crisis
  action_annotation_relationships:
    - subject: <Erythrocytapheresis>
      predicate: <TREATS>
      object: <Vascular necrosis of the right femoral head>
      qualifier: <Sickle Cell Disease>
      subject_qualifier: <Not available>
      object_qualifier: <Not available>
      subject_extension: <Not available>
      object_extension: <Not available>
    - subject: Total hip arthroplasty
      predicate: TREATS
      object: HP:0012531
      qualifier: MONDO:0011382
    - subject: Total hip arthroplasty
      predicate: TREATS
      object: Limitations of day-to-day activities
      qualifier: MONDO:0011382
    - subject: Erythrocytapheresis
      predicate: PREVENTS
      object: Vaso-occlusive crisis
      qualifier: MONDO:0011382
named_entities:
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MONDO:0100096
    label: SARS-CoV-2
  - id: MONDO:0007374
    label: Sickle cell disease (SCD)
  - id: HP:0100602
    label: Preeclampsia
  - id: HP:0001511
    label: Intrauterine growth restriction
  - id: CHEBI:44423
    label: Hydroxyurea (HU)
  - id: CHEBI:35143
    label: Haemoglobin (Hb)
  - id: HP:0001622
    label: Preterm delivery
  - id: CHEBI:50858
    label: corticosteroids
  - id: HP:0032654
    label: Endothelial dysfunction
  - id: HP:0012418
    label: Hypoxia
  - id: HP:0001409
    label: Portal hypertension
  - id: MAXO:0001001
    label: Gene therapies
  - id: MAXO:0000756
    label: Transfusion
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: MAXO:0001298
    label: therapy
  - id: MAXO:0009047
    label: Total hip replacement (THR)
  - id: CHEBI:22720
    label: Benzodiazepines
  - id: MONDO:0006079
    label: Acute chest syndrome (ACS)
  - id: CHEBI:24859
    label: Iodine
  - id: MONDO:0005632
    label: Acute chest syndrome
  - id: CHEBI:17334
    label: penicillin
  - id: MAXO:0000118
    label: immunizations
  - id: HP:0001903
    label: anemia
  - id: HP:0001297
    label: stroke
  - id: HP:0012532
    label: Chronic pain
  - id: CHEBI:3216
    label: Buprenorphine
  - id: HP:0001518
    label: Low birth weight
  - id: MAXO:0001006
    label: Full blood count
  - id: MAXO:0000825
    label: Reticulocyte count
  - id: MAXO:0000427
    label: Brain magnetic resonance imaging (MRI)
  - id: HP:0012592
    label: albuminuria
  - id: HP:0100543
    label: cognitive dysfunction
  - id: HP:0000739
    label: anxiety
  - id: HP:0010783
    label: Redness
  - id: CHEBI:33281
    label: antibiotics
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:145536
    label: Motixafortide
  - id: CHEBI:114786
    label: sodium metabisulfite
  - id: CHEBI:15365
    label: aspirin
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0012622
    label: CKD
  - id: MAXO:0000969
    label: optical coherence tomography (OCT)
  - id: HP:0000505
    label: visual impairment
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:82557
    label: treosulfan
  - id: CHEBI:9570
    label: thiotepa
  - id: HP:0100603
    label: Hypertensive disorder of pregnancy (HDP)
  - id: CHEBI:26308
    label: unweighted polygenic risk score (PRS)
  - id: CHEBI:35480
    label: Analgesics
  - id: HP:0012213
    label: Decreased glomerular filtration rate
  - id: HP:0012398
    label: Peripheral oedema
  - id: HP:0001685
    label: Cardiac fibrosis
  - id: MONDO:0005570
    label: hematologic diseases
  - id: HP:0001871
    label: hematologic diseases
  - id: HP:0001712
    label: Left ventricular hypertrophy
  - id: HP:0007760
    label: SCD
  - id: MAXO:0000149
    label: Hematopoietic cell transplant (HCT)
  - id: MAXO:0010203
    label: Echocardiography
  - id: HP:0012531
    label: Pain
  - id: CHEBI:51371
    label: muscle relaxants
  - id: HP:0002140
    label: Arterial ischemic stroke
  - id: MONDO:0019402
    label: Thalassemia major
  - id: MAXO:0000536
    label: Chorionic villus sampling (CVS)
  - id: MONDO:0020380
    label: Sickle cell anemia (SCA)
  - id: MONDO:0005161
    label: Human papillomavirus (HPV) infection
  - id: MAXO:0000759
    label: HPV vaccination
  - id: MAXO:0000447
    label: Surgical removal
  - id: HP:0033138
    label: Right atrial thrombus
  - id: HP:0000989
    label: pruritus
  - id: MAXO:0010041
    label: skin grafting
